In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
Authors
Keywords
-
Journal
Frontiers in Chemistry
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-08
DOI
10.3389/fchem.2019.00873
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase - 6 Inhibitors
- (2019) Dusan Ruzic et al. Molecular Informatics
- An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking
- (2019) Jin Li et al. Interdisciplinary Sciences-Computational Life Sciences
- Defining a new nomenclature for the structures of active and inactive kinases
- (2019) Vivek Modi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
- (2019) Shaoyong Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modulating Protein-Protein Interactions with Visible-Light Responsive Peptide Backbone Photoswitches
- (2019) Lea Albert et al. CHEMBIOCHEM
- Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis
- (2019) Tahia K. Mohamed et al. BIOORGANIC CHEMISTRY
- Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐ b ]pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 1
- (2019) Akira Kaieda et al. ChemMedChem
- Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
- (2019) Collins et al. Cancers
- Erdafitinib: First Global Approval
- (2019) Anthony Markham DRUGS
- Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases
- (2019) Christine Yueh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular dynamics investigation on the Asciminib resistance mechanism of I502L and V468F mutations in BCR-ABL
- (2019) Jiu-Yu Zhan et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- In Silico Reoptimization of Binding Affinity and Drug-Resistance Circumvention Ability in Kinase Inhibitors: A Case Study with RL-45 and Src Kinase
- (2019) Jaya Krishna Koneru et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
- (2019) Hansaim Lim et al. PLoS Computational Biology
- DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences
- (2019) Ingoo Lee et al. PLoS Computational Biology
- Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
- (2019) Chune Yu et al. Frontiers in Immunology
- 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation
- (2019) Mahitab K. Sobhy et al. BIOORGANIC CHEMISTRY
- Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches
- (2019) Jelica Vucicevic et al. CURRENT MEDICINAL CHEMISTRY
- Reaction-Based Enumeration, Active Learning, and Free Energy Calculations To Rapidly Explore Synthetically Tractable Chemical Space and Optimize Potency of Cyclin-Dependent Kinase 2 Inhibitors
- (2019) Kyle D. Konze et al. Journal of Chemical Information and Modeling
- Enhanced sampling in molecular dynamics
- (2019) Yi Isaac Yang et al. JOURNAL OF CHEMICAL PHYSICS
- Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies
- (2019) Saw Simeon et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Deep learning enables rapid identification of potent DDR1 kinase inhibitors
- (2019) Alex Zhavoronkov et al. NATURE BIOTECHNOLOGY
- Discovery of a novel protein kinase C activator from Croton tiglium for inhibition of non-small cell lung cancer
- (2019) Yuwei Wang et al. PHYTOMEDICINE
- Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening
- (2019) Jian Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents
- (2019) Tao Wang et al. MOLECULES
- Multi-Target Chemometric Modelling, Fragment Analysis and Virtual Screening with ERK Inhibitors as Potential Anticancer Agents
- (2019) Amit Kumar Halder et al. MOLECULES
- Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking
- (2019) Yongqiang Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives
- (2019) Ahmed I. Khodair et al. CARBOHYDRATE RESEARCH
- In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents
- (2019) Sudhan Debnath et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cells
- (2019) Bingbing Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II
- (2018) Charlott Platzer et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual Drug Targeting of Mutant Bcr-Abl Induces Inactive Conformation: New Strategy for the Treatment of Chronic Myeloid Leukemia and Overcoming Monotherapy Resistance
- (2018) Ahmed A. El Rashedy et al. CHEMISTRY & BIODIVERSITY
- Structure-based prediction of protein allostery
- (2018) Joe G Greener et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Discovery of hidden allosteric sites as novel targets for allosteric drug design
- (2018) Shaoyong Lu et al. DRUG DISCOVERY TODAY
- Reinforced Adversarial Neural Computer for de Novo Molecular Design
- (2018) Evgeny Putin et al. Journal of Chemical Information and Modeling
- Predicting the Conformational Variability of Abl Tyrosine Kinase using Molecular Dynamics Simulations and Markov State Models
- (2018) Yilin Meng et al. Journal of Chemical Theory and Computation
- Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia
- (2018) Haiyan Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- De Novo Design of Bioactive Small Molecules by Artificial Intelligence
- (2018) Daniel Merk et al. Molecular Informatics
- PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials
- (2018) Fabrice Carles et al. MOLECULES
- CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction
- (2018) Youjun Xu et al. NUCLEIC ACIDS RESEARCH
- AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
- (2018) Min Huang et al. NUCLEIC ACIDS RESEARCH
- The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim
- (2018) Lazaro E. Aira et al. ONCOGENE
- Markov models for the elucidation of allosteric regulation
- (2018) Ushnish Sengupta et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Computer-Aided Drug Design in Epigenetics
- (2018) Wenchao Lu et al. Frontiers in Chemistry
- Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
- (2018) Joseph Schoepfer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors
- (2018) Abd Amr et al. MOLECULES
- Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1
- (2018) Abdulkarim Najjar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data
- (2018) Antonio-Jesús Banegas-Luna et al. Future Medicinal Chemistry
- Studies on the Dual Activity of EGFR and HER-2 Inhibitors Using Structure-Based Drug Design Techniques
- (2018) Rafaela de Angelo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predictive Models for Designing Potent Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia for Understanding its Molecular Mechanism of Resistance by Molecular Docking and Dynamics Simulations
- (2018) Anu R Melge et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Combining a QSAR Approach and Structural Analysis to Derive an SAR Map of Lyn Kinase Inhibition
- (2018) Imane Naboulsi et al. MOLECULES
- Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors
- (2018) Gaomin Zhang et al. MOLECULES
- PubChem 2019 update: improved access to chemical data
- (2018) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- ChEMBL: towards direct deposition of bioassay data
- (2018) David Mendez et al. NUCLEIC ACIDS RESEARCH
- Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
- (2018) Bruno J. Neves et al. Frontiers in Pharmacology
- In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure–activity relationships and molecular docking
- (2018) Jiao-Long Wang et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Synthesis, and anti-proliferative, Pim-1 kinase inhibitors and molecular docking of thiophenes derived from estrone
- (2018) Rafat M. Mohareb et al. BIOORGANIC CHEMISTRY
- Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine Residues
- (2017) Weilin Zhang et al. Journal of Chemical Information and Modeling
- Improved Method for the Identification and Validation of Allosteric Sites
- (2017) Kun Song et al. Journal of Chemical Information and Modeling
- Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
- (2017) Tim Fischer et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors
- (2017) Xiuqin Hu et al. Frontiers in Chemistry
- Progress towards a public chemogenomic set for protein kinases and a call for contributions
- (2017) David H. Drewry et al. PLoS One
- Alloscore: a method for predicting allosteric ligand–protein interactions
- (2016) Shuai Li et al. BIOINFORMATICS
- A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin
- (2016) Jelica Vucicevic et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Protein Allostery and Conformational Dynamics
- (2016) Jingjing Guo et al. CHEMICAL REVIEWS
- Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
- (2016) Jeffrey R. Wagner et al. CHEMICAL REVIEWS
- Discovery of Non-ATP-Competitive Inhibitors of Polo-like Kinase 1
- (2016) Taikangxiang Yun et al. ChemMedChem
- Venetoclax: First Global Approval
- (2016) Emma D. Deeks DRUGS
- Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs
- (2016) Zarko Gagic et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Advanced molecular dynamics simulation methods for kinase drug discovery
- (2016) Samia Aci-Sèche et al. Future Medicinal Chemistry
- Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?
- (2016) Serge Christmann-Franck et al. Journal of Chemical Information and Modeling
- Motions of Allosteric and Orthosteric Ligand-Binding Sites in Proteins are Highly Correlated
- (2016) Xiaomin Ma et al. Journal of Chemical Information and Modeling
- HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase
- (2016) Giuseppina La Sala et al. Journal of Chemical Theory and Computation
- Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay
- (2016) Benjamin Merget et al. JOURNAL OF MEDICINAL CHEMISTRY
- QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells
- (2016) Zarko Gagic et al. Journal of the Taiwan Institute of Chemical Engineers
- The Next Era: Deep Learning in Pharmaceutical Research
- (2016) Sean Ekins PHARMACEUTICAL RESEARCH
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
- (2016) Margaret L. Wong et al. Proteome Science
- Predictive proteochemometric models for kinases derived from 3D protein field-based descriptors
- (2016) Vigneshwari Subramanian et al. MedChemComm
- Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs
- (2016) Fereshteh Shiri et al. SAUDI PHARMACEUTICAL JOURNAL
- Identification of a Novel Inhibitory Allosteric Site in p38α
- (2016) Patricia Gomez-Gutierrez et al. PLoS One
- Mnks, eIF4E phosphorylation and cancer
- (2015) Christopher G. Proud Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The ABC of protein kinase conformations
- (2015) Henrik Möbitz BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Tumor Progression Locus 2 (Tpl2) Kinase as a Novel Therapeutic Target for Cancer: Double-Sided Effects of Tpl2 on Cancer
- (2015) Hye Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors
- (2015) Nannan Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Classification of Current Scoring Functions
- (2015) Jie Liu et al. Journal of Chemical Information and Modeling
- Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking
- (2015) T. Justin Rettenmaier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacophore modeling, drug design and virtual screening on multi-targeting procognitive agents approaching histaminergic pathways
- (2015) Katarina Nikolic et al. Journal of the Taiwan Institute of Chemical Engineers
- 3D-QSAR studies and pharmacophore identification of AT1 receptor antagonists
- (2015) Miralem Smajić et al. MEDICINAL CHEMISTRY RESEARCH
- Virtual screening strategies: Recent advances in the identification and design of anti-cancer agents
- (2015) Vikash Kumar et al. METHODS
- Molecular Docking and Structure-Based Drug Design Strategies
- (2015) Leonardo Ferreira et al. MOLECULES
- The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins
- (2015) Dima Kozakov et al. Nature Protocols
- Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
- (2015) Eunyoung Park et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A historical overview of protein kinases and their targeted small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Allosteric small-molecule kinase inhibitors
- (2015) Peng Wu et al. PHARMACOLOGY & THERAPEUTICS
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
- (2015) Dávid Bajusz et al. Journal of Cheminformatics
- Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
- (2015) Eunyoung Park et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2
- (2014) Giulio Rastelli et al. CELL CYCLE
- Assessing the accuracy of physical models used in protein-folding simulations: quantitative evidence from long molecular dynamics simulations
- (2014) Stefano Piana et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Protein-Protein Interface Analysis and Hot Spots Identification for Chemical Ligand Design
- (2014) Jing Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular Mechanics
- (2014) Kenno Vanommeslaeghe et al. CURRENT PHARMACEUTICAL DESIGN
- Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
- (2014) Evanthia Lionta et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil–indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease
- (2014) Oscar M. Bautista-Aguilera et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In silico screening and study of novel ERK2 inhibitors using 3D QSAR, docking and molecular dynamics
- (2014) Sofiene Larif et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Exploring a Non-ATP Pocket for Potential Allosteric Modulation of PI3Kα
- (2014) Paraskevi Gkeka et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Exploration of potential EGFR inhibitors: a combination of pharmacophore-based virtual screening, atom-based 3D-QSAR and molecular docking analysis
- (2014) Arumugam Sudha et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Chemistry: Chemical con artists foil drug discovery
- (2014) Jonathan Baell et al. NATURE
- Activation pathway of Src kinase reveals intermediate states as targets for drug design
- (2014) Diwakar Shukla et al. Nature Communications
- Imidazoline-1 Receptor Ligands as Apoptotic Agents: Pharmacophore Modeling and Virtual Docking Study
- (2013) Katarina Nikolic et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Binding Site Detection and Druggability Prediction of Protein Targets for Structure- Based Drug Design
- (2013) Yaxia Yuan et al. CURRENT PHARMACEUTICAL DESIGN
- Structure-based Discovery of Antagonists of Nuclear Receptor LRH-1
- (2013) Cindy Benod et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Visually Interpretable Models of Kinase Selectivity Related Features Derived from Field-Based Proteochemometrics
- (2013) Vigneshwari Subramanian et al. Journal of Chemical Information and Modeling
- QSAR Modeling: Where Have You Been? Where Are You Going To?
- (2013) Artem Cherkasov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments
- (2013) Erik Laurini et al. Molecular Oncology
- Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: inhibition of Jak2 inactivates Lyn kinase
- (2013) S Chakraborty et al. Blood Cancer Journal
- Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
- (2012) Zhizhou Fang et al. ACS Chemical Biology
- Biomolecular Simulation: A Computational Microscope for Molecular Biology
- (2012) Ron O. Dror et al. Annual Review of Biophysics
- Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation
- (2012) Fabrizio Giordanetto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2
- (2012) Mathew P. Martin et al. CHEMBIOCHEM
- Molecular Dynamics of Protein Kinase-Inhibitor Complexes: A Valid Structural Information
- (2012) Julio Caballero et al. CURRENT PHARMACEUTICAL DESIGN
- New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
- (2012) Vandana Lamba et al. CURRENT PHARMACEUTICAL DESIGN
- Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome
- (2012) Baichun Yang et al. JOURNAL OF APPLIED TOXICOLOGY
- ZINC: A Free Tool to Discover Chemistry for Biology
- (2012) John J. Irwin et al. Journal of Chemical Information and Modeling
- Are Protein Force Fields Getting Better? A Systematic Benchmark on 524 Diverse NMR Measurements
- (2012) Kyle A. Beauchamp et al. Journal of Chemical Theory and Computation
- Toward understanding the molecular basis for chemical allosteric modulator design
- (2012) Qi Wang et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition
- (2012) A Astanehe et al. ONCOGENE
- Refinement of protein structure homology models via long, all-atom molecular dynamics simulations
- (2012) Alpan Raval et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Discovery of a Novel Chemotype of Tyrosine Kinase Inhibitors by Fragment-Based Docking and Molecular Dynamics
- (2012) Hongtao Zhao et al. ACS Medicinal Chemistry Letters
- Discovery of a Potential Allosteric Ligand Binding Site in CDK2
- (2011) Stephane Betzi et al. ACS Chemical Biology
- The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
- (2011) Arvin C. Dar et al. Annual Review of Biochemistry
- Drugs for Allosteric Sites on Receptors
- (2011) Cody J. Wenthur et al. Annual Review of Pharmacology and Toxicology
- The rise and fall of gatekeeper mutations? TheBCR-ABL1T315I paradigm
- (2011) Don L. Gibbons et al. CANCER
- Molecular complexity and fragment-based drug discovery: ten years on
- (2011) Andrew R Leach et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking
- (2011) Ji-Xia Ren et al. Journal of Chemical Information and Modeling
- Fragment-based lead discovery: challenges and opportunities
- (2011) Chaohong Sun et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors
- (2011) Mahesh Kumar Teli et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
- (2011) Seiichi Okabe et al. Journal of Hematology & Oncology
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Predicting a small molecule-kinase interaction map: A machine learning approach
- (2011) Fabian Buchwald et al. Journal of Cheminformatics
- A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug design
- (2011) Malleshappa N. Noolvi et al. Journal of Saudi Chemical Society
- The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity
- (2010) Fouzia Machrouhi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening
- (2010) Fabrizio Giordanetto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach
- (2010) Julen Oyarzabal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Binding or Bending: Distinction of Allosteric Abl Kinase Agonists from Antagonists by an NMR-Based Conformational Assay
- (2010) Wolfgang Jahnke et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
- (2010) Brian B. Hasinoff TOXICOLOGY AND APPLIED PHARMACOLOGY
- Protein kinases: evolution of dynamic regulatory proteins
- (2010) Susan S. Taylor et al. TRENDS IN BIOCHEMICAL SCIENCES
- Characterization of the CHK1 Allosteric Inhibitor Binding Site
- (2009) Darin Vanderpool et al. BIOCHEMISTRY
- Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors
- (2009) Ariamala Gopalsamy et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fpocket: An open source platform for ligand pocket detection
- (2009) Vincent Le Guilloux et al. BMC BIOINFORMATICS
- Long-timescale molecular dynamics simulations of protein structure and function
- (2009) John L Klepeis et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Suitability of GRIND-Based Principal Properties for the Description of Molecular Similarity and Ligand-Based Virtual Screening
- (2009) Ángel Durán et al. Journal of Chemical Information and Modeling
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
- (2009) Fabio Zuccotto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
- (2008) Y. Yamanishi et al. BIOINFORMATICS
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4 (CDK4)
- (2008) Hwei-Ru Tsou et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started